Literature DB >> 22121874

In junk we trust: repetitive DNA, epigenetics and facioscapulohumeral muscular dystrophy.

Maria V Neguembor1, Davide Gabellini.   

Abstract

Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal dominant myopathy with a peculiar etiology. Unlike most genetic disorders, FSHD is not caused by mutations in a protein-coding gene. Instead, it is associated with contraction of the D4Z4 macrosatellite repeat array located at 4q35. Interestingly, D4Z4 deletion is not sufficient per se to cause FSHD. Moreover, the disease severity, its rate of progression and the distribution of muscle weakness display great variability even among close family relatives. Hence, additional genetic and epigenetic events appear to be required for FSHD pathogenesis. Indeed, recent findings suggest that virtually all levels of epigenetic regulation, from DNA methylation to higher order chromosomal architecture, exhibit alterations in the disease locus causing deregulation of 4q35 gene expression, ultimately leading to FSHD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 22121874     DOI: 10.2217/epi.10.8

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  20 in total

1.  A novel molecular mechanism in human genetic disease: a DNA repeat-derived lncRNA.

Authors:  Daphne S Cabianca; Valentina Casa; Davide Gabellini
Journal:  RNA Biol       Date:  2012-10-01       Impact factor: 4.652

Review 2.  Alternative splicing and muscular dystrophy.

Authors:  Mariaelena Pistoni; Claudia Ghigna; Davide Gabellini
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

3.  Stable C0T-1 repeat RNA is abundant and is associated with euchromatic interphase chromosomes.

Authors:  Lisa L Hall; Dawn M Carone; Alvin V Gomez; Heather J Kolpa; Meg Byron; Nitish Mehta; Frank O Fackelmayer; Jeanne B Lawrence
Journal:  Cell       Date:  2014-02-27       Impact factor: 41.582

Review 4.  The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy.

Authors:  Daphne Selvaggia Cabianca; Davide Gabellini
Journal:  J Cell Biol       Date:  2010-12-13       Impact factor: 10.539

5.  Condensin and Hmo1 Mediate a Starvation-Induced Transcriptional Position Effect within the Ribosomal DNA Array.

Authors:  Danni Wang; Andres Mansisidor; Gayathri Prabhakar; Andreas Hochwagen
Journal:  Cell Rep       Date:  2016-01-28       Impact factor: 9.423

6.  Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis.

Authors:  Takako Iida Jones; Jennifer C J Chen; Fedik Rahimov; Sachiko Homma; Patricia Arashiro; Mary Lou Beermann; Oliver D King; Jeffrey B Miller; Louis M Kunkel; Charles P Emerson; Kathryn R Wagner; Peter L Jones
Journal:  Hum Mol Genet       Date:  2012-07-13       Impact factor: 6.150

7.  Evolutionary history of linked D4Z4 and Beta satellite clusters at the FSHD locus (4q35).

Authors:  Marta Giussani; Maria Francesca Cardone; Beatrice Bodega; Enrico Ginelli; Raffaella Meneveri
Journal:  Genomics       Date:  2012-07-21       Impact factor: 5.736

8.  A Human Pluripotent Stem Cell Model of Facioscapulohumeral Muscular Dystrophy-Affected Skeletal Muscles.

Authors:  Leslie Caron; Devaki Kher; Kian Leong Lee; Robert McKernan; Biljana Dumevska; Alejandro Hidalgo; Jia Li; Henry Yang; Heather Main; Giulia Ferri; Lisa M Petek; Lorenz Poellinger; Daniel G Miller; Davide Gabellini; Uli Schmidt
Journal:  Stem Cells Transl Med       Date:  2016-05-23       Impact factor: 6.940

9.  A repetitive elements perspective in Polycomb epigenetics.

Authors:  Valentina Casa; Davide Gabellini
Journal:  Front Genet       Date:  2012-10-08       Impact factor: 4.599

10.  Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD).

Authors:  Mariaelena Pistoni; Lily Shiue; Melissa S Cline; Sergia Bortolanza; Maria Victoria Neguembor; Alexandros Xynos; Manuel Ares; Davide Gabellini
Journal:  PLoS Genet       Date:  2013-01-03       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.